|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2003-2-17
|
|
pubmed:abstractText |
Renal itch is a relatively common and distressing problem for patients with chronic renal failure. Ondansetron, a serotonin type 3 receptor antagonist was developed for relief of chemotherapy induced nausea. Recently, anecdotal reports describe relief of renal itch with ondansetron.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
148
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
314-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12588385-Antipruritics,
pubmed-meshheading:12588385-Double-Blind Method,
pubmed-meshheading:12588385-Female,
pubmed-meshheading:12588385-Humans,
pubmed-meshheading:12588385-Kidney Failure, Chronic,
pubmed-meshheading:12588385-Male,
pubmed-meshheading:12588385-Middle Aged,
pubmed-meshheading:12588385-Ondansetron,
pubmed-meshheading:12588385-Patient Satisfaction,
pubmed-meshheading:12588385-Pruritus,
pubmed-meshheading:12588385-Renal Dialysis,
pubmed-meshheading:12588385-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
A randomized, placebo-controlled, double-blind trial of ondansetron in renal itch.
|
|
pubmed:affiliation |
Department of Dermatology, South Cleveland Hospital, Middlesbrough, TS4 3BW, UK. drmichellemurphy@eircom.net
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
